Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BIRC3 | Q13489 | 12/20 | 0.76 |
| ▸ | XIAP | P98170 | 11/20 | 0.76 |
| ▸ | BIRC2 | Q13490 | 3/20 | 0.76 |
| ▸ | BIRC7 | Q96CA5 | 1/20 | 0.76 |
| ▸ | TNF | P01375 | 12/20 | 0.62 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12946318 | 0.97 | BIRC3 (0.80) | BIRC3XIAPBIRC2BIRC7TNF | |
| SCHEMBL950069 | 0.97 | BIRC3 (0.80) | BIRC3XIAPBIRC2BIRC7TNF | |
| SCHEMBL14848175 | 0.97 | BIRC3 (0.80) | BIRC3XIAPBIRC2BIRC7TNF | |
| SCHEMBL30416136 | 0.97 | BIRC3 (0.80) | BIRC3XIAPBIRC2BIRC7TNF | |
| SCHEMBL5037496 | 0.97 | BIRC3 (0.80) | BIRC3XIAPBIRC2BIRC7TNF | |
| SCHEMBL14848206 | 0.97 | BIRC3 (0.80) | BIRC3XIAPBIRC2BIRC7TNF | |
| SCHEMBL24767185 | 0.96 | BIRC3 (0.70) | BIRC3XIAPBIRC2BIRC7TNF | |
| SCHEMBL25461046 | 0.94 | BIRC3 (0.87) | BIRC3XIAPBIRC2BIRC7TNF | |
| SCHEMBL24767336 | 0.94 | BIRC3 (0.75) | BIRC3XIAPBIRC2BIRC7TNF | |
| SCHEMBL21260485 | 0.94 | BIRC3 (0.75) | BIRC3XIAPBIRC2BIRC7TNF |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220396566-A1 | LIVER TARGETING DRUG, PHARMACEUTICAL COMPOSITION AND USE THEREOF | DU, Jessica Xinyun | 2022-12-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220396566-A1 | LIVER TARGETING DRUG, PHARMACEUTICAL COMPOSITION AND USE THEREOF | SLC10A1, ABCB11, CYP7A1 | BIRC3 4759/4885XIAP 2711/4885BIRC2 4828/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.